|
Jun 30
|
GeNeuro Announces Approval of All Resolutions Proposed at Extraordinary General Meeting
|
|
May 29
|
Availability of documents and information for the annual shareholders’ meeting of June 12, 2024
|
|
Nov 28
|
GeNeuro Announces Completion of Recruitment of Its Long-COVID Phase 2 Trial and Confirms Top-Line Results for June 2024
|